News

OSE Immunotherapeutics Reveals Exciting New Data on Lusvertikimab

OSE Immunotherapeutics Reveals Exciting New Data on Lusvertikimab

OSE Immunotherapeutics Unveils Promising Clinical Findings

OSE Immunotherapeutics SA, a trailblazer in developing innovative therapies for immuno-oncology and immuno-inflammation, is set to present significant new data regarding Lusvertikimab at the prestigious Digestive Disease Week (DDW) 2025 conference. The highlights of this presentation are drawn from a pivotal 24-week Open Label Extension (OLE) period of the Phase 2 clinical trial focusing on ulcerative colitis and will take place in San Diego.

Key Insights on Lusvertikimab and Ulcerative Colitis

Lusvertikimab, an anti-IL-7 receptor monoclonal antibody, has shown a strong safety and efficacy profile during its initial trial phases. This upcoming oral presentation aims to share newly obtained clinical insights from the OLE study, where patients with moderate to severe ulcerative colitis underwent further evaluation from Week 10 to Week 34. The goal is to provide an in-depth understanding of Lusvertikimab's long-term benefits, which is essential for advancing treatment options for chronic autoimmune conditions.

Details of the Presentation

The oral presentation titled "LUSVERTIKIMAB, A FIRST IN CLASS IL7 RECEPTOR ANTAGONIST, IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A MULTICCENTER RANDOMIZED PLACEBO-CONTROLLED PHASE II STUDY" is scheduled for May 5, 2025, at 4:45 PM Pacific Time. It will be featured in the session focusing on Clinical Trials in Inflammatory Bowel Disease (IBD), specifically addressing biologics and emerging therapies.

The Challenge of Ulcerative Colitis

Ulcerative colitis (UC) remains a persistent challenge in gastrointestinal health, characterized by inflammation and ulceration in the gastrointestinal tract caused by an overactive immune system. Currently, UC affects millions of individuals across major global regions, including the US, Europe, and Japan. Despite available treatment options, the remission rates are disappointingly low, with many patients experiencing limited benefits and some resorting to surgery as a final solution.

OSE Immunotherapeutics: A Commitment to Innovation

At OSE Immunotherapeutics, the focus is on creating first-in-class therapeutics. The company partners with leading academic institutions and biopharmaceutical companies, striving to address urgent patient needs through groundbreaking medical advancements. With bases in both Nantes and Paris, the company's commitment to pioneering treatments continues to shape the landscape of therapeutic options available to patients facing severe health challenges.

Upcoming Developments and Future Directions

The data presented at DDW 2025 is expected to bolster the case for continuing the development of Lusvertikimab, not only for ulcerative colitis but also for other chronic autoimmune diseases. Insights derived from the clinical trial findings will be critical for refining treatment strategies and improving patient outcomes.

Contact Information for OSE Immunotherapeutics

For further information about OSE Immunotherapeutics and its innovative developments, stakeholders can reach out to:

Fiona Olivier
fiona.olivier@ose-immuno.com

Sylvie Détry
sylvie.detry@ose-immuno.com

French Media Contact:
Florence Portejoie, FP2COM
fportejoie@fp2com.fr
+33 6 07 768 283

U.S. Media Contact:
Kate Barrette, Rooney Partners LLC
kbarrette@rooneypartners.com
+1 212 223 0561

Frequently Asked Questions

What is Lusvertikimab?

Lusvertikimab is an innovative monoclonal antibody targeting the IL-7 receptor, developed by OSE Immunotherapeutics for the treatment of ulcerative colitis.

When will OSE be presenting the new findings?

The new findings on Lusvertikimab will be presented on May 5, 2025, at the Digestive Disease Week conference.

What are the key benefits of Lusvertikimab?

Initial findings suggest that Lusvertikimab may offer long-term benefits and safety for patients suffering from moderate to severe ulcerative colitis.

How prevalent is ulcerative colitis globally?

UC affects approximately 3.3 million patients across major regions, including the US, Europe, and Japan.

How does OSE Immunotherapeutics contribute to the biotech field?

OSE Immunotherapeutics is committed to developing first-in-class therapies and collaborates with leading institutions to address unmet medical needs in immuno-oncology and immuno-inflammation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 2

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 2

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 0

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 4

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 5

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 4

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 4

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 3

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab Streamlines Portfolio: Focus on Late-Stage Cancer Assets

Updated Category News Views 86

Genmab Enhances Focus on Promising Cancer Treatments Genmab A/S (NASDAQ: GMAB) has made a decisive move in its clinical strategy by announcing the discontinuation of further clinical development for acasunlimab. This decision represents a thoughtful pivot towards prioritizing late-stage assets that hold the most promise for future value creation. Strategic Rethink Amidst...

Continue Reading
NCLA's Legal Victory: Reversal of ATF's Bump-Stock Ban

Updated Category News Views 135

NCLA Achieves Legal Victory Over ATF's Bump-Stock Ban In an empowering turnaround, the New Civil Liberties Alliance (NCLA) has successfully persuaded the U.S. District Court to vacate the Bureau of Alcohol, Tobacco, Firearms and Explosives' (ATF) controversial ban on bump stocks. This landmark ruling marks a significant moment for civil liberties, affirming the rights of...

Continue Reading
Pacsun Unveils Team Tyson Collection for Upcoming Match

Updated Category News Views 97

Pacsun Launches Exclusive Team Tyson Merchandise Youth lifestyle retailer Pacsun is making waves in the fashion and sports arena with the launch of its latest collection called Team Tyson. This exclusive line gives fans and boxing enthusiasts a chance to grab exclusive merchandise at a special event designed to celebrate the upcoming match between Jake Paul and Mike...

Continue Reading
Albertsons Companies Inc. Reports Robust Q3 Results for 2024

Updated Category News Views 190

Albertsons Companies, Inc. Reports Strong Third Quarter Fiscal 2024 Results Albertsons Companies, Inc. (NYSE: ACI) announced its financial performance for the third quarter of fiscal 2024. This report highlights the company's profitability and growth strategies amidst a cautious consumer environment. Third Quarter Fiscal 2024 Highlights During this quarter, the company...

Continue Reading
India Faces Growing Trade Deficit Amid Gold Import Surge

Updated Category News Views 257

India's Trade Deficit Hits a New High Recent trade statistics from India reveal a troubling trend: the merchandise trade deficit has reached its highest point in ten months. In August, the deficit hit $29.65 billion, which has caught the attention of economists and analysts alike. This rise is primarily due to a sharp increase in gold imports, coupled with a decline in...

Continue Reading